Related references
Note: Only part of the references are listed.Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients
Morten Petersen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Pharmacogenetics: From Bench to Byte-An Update of Guidelines
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
Paul M. Ridker et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Clopidogrel Resistance
Jaya Prakash Sugunaraj et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
Dirk Sibbing et al.
CIRCULATION (2010)
Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients
E. Pautas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
D. Voora et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Pharmacogenetics of Oral Anticoagulant Therapy
T. Schalekamp et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts et al.
EUROPEAN HEART JOURNAL (2010)
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study
Olga A. Iakoubova et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
VKORC1-1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement
Helene Puehringer et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Combination of Clopidogrel and Proton Pump Inhibitors: Implications for Clinicians
Marie Tran et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes The PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies
Themistocles L. Assimes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
Jessica L. Mega et al.
LANCET (2010)
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin et al.
LANCET (2010)
Genome-wide association studies in pharmacogenomics
Ann K. Daly
NATURE REVIEWS GENETICS (2010)
Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
Guillaume Pare et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
Mathew J. Barber et al.
PLOS ONE (2010)
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation
Ankie Harmsze et al.
PHARMACOGENETICS AND GENOMICS (2010)
Haplotypes of the adrenergic system predict the blood pressure response to β-blockers in women with essential hypertension
Fabiana Filigheddu et al.
PHARMACOGENOMICS (2010)
Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform
Tristan M. Sissung et al.
PHARMACOGENOMICS (2010)
Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement- A systematic review and meta analysis
Limei Yang et al.
THROMBOSIS RESEARCH (2010)
Gln27→Gluβ2-Adrenergic Receptor Polymorphism in Heart Failure Patients: Differential Clinical and Oxidative Response to Carvedilol
Rodrigo Troncoso et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
The largest prospective warfarin-treated cohort supports genetic forecasting
Mia Wadelius et al.
BLOOD (2009)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Frederick G. Kushner et al.
CIRCULATION (2009)
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
Jessica L. Mega et al.
CIRCULATION (2009)
Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
John F. Thompson et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
The genetics of antiplatelet drug resistance
G. Feher et al.
CLINICAL GENETICS (2009)
Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users
M. J. Bijl et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Impact of the CYP2D6 Genotype on the Clinical Effects of Metoprolol: A Prospective Longitudinal Study
T. Rau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Treatment of Acute Myocardial Infarction in Patients with Stimulant ST-segment Elevation
Frans Van de Werf et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Influence of CYP2C9 genotype on warfarin dose requirements-a systematic review and meta-analysis
Jonatan D. Lindh et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
A genome-wide association study of acenocoumarol maintenance dosage
Martina Teichert et al.
HUMAN MOLECULAR GENETICS (2009)
Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene
Peter Staritz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer A Dose-Escalation Study
Patrick Gladding et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Clopidogrel Resistance: Pharmacokinetic or Pharmacogenetic?
Neville F. Ford
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Association of TNF-α promoter polymorphisms with aspirin-induced urticaria
J. H. Choi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2009)
Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
Kirsten Neudoerffer Kangelaris et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Pharmacogenetics in Cardiovascular Antithrombotic Therapy
Francisco Marin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The SLCO1B1*5 Genetic Variant Is Associated With Statin-Induced Side Effects
Deepak Voora et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Common variants at 30 loci contribute to polygenic dyslipidemia
Sekar Kathiresan et al.
NATURE GENETICS (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
Kyle J. Ellis et al.
PHARMACOGENOMICS (2009)
APOE gene polymorphisms and response to statin therapy
E. Zintzaras et al.
PHARMACOGENOMICS JOURNAL (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Implications for emergency department practice
Charles V. Pollack et al.
ANNALS OF EMERGENCY MEDICINE (2008)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Pharmacogenetics of aspirin resistance: a comprehensive systematic review
Timothy Goodman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacogenetics: From bench to byte
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
M. A. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin
Elena Piazuelo et al.
CLINICAL THERAPEUTICS (2008)
CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction
Jakub J. Regieli et al.
EUROPEAN HEART JOURNAL (2008)
Ile164 variant of beta 2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment
Mathew D. Littlejohn et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Role of beta adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis
Amal Muthumala et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response An Analysis From the PRINC (Plavix Response in Coronary Intervention) Trial
Patrick Gladding et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2008)
Association between a TGFβ1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population
H. -J. Park et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2008)
Effects of Polymorphism of the β1 Adrenoreceptor and CYP2D6 on the Therapeutic Effects of Metoprolol
H. Yuan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials
Olga A. Iakoubova et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes
Olga A. Iakoubova et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Cristen J. Willer et al.
NATURE GENETICS (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pharmacogenetics of apolipoprtein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
Tuomo Nieminen et al.
PHARMACOGENOMICS (2008)
CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
Tobias Geisler et al.
PHARMACOGENOMICS (2008)
Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: Prevalence of related drug use
Felix W. Frueh et al.
PHARMACOTHERAPY (2008)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
Frans Van de Werf et al.
EUROPEAN HEART JOURNAL (2008)
Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes: The task force for the diagnosis and treatment of Non-ST-segment elevation acute coronary syndromes of the European society of cardiology
Claudio Rapezzi et al.
EUROPEAN HEART JOURNAL (2008)
Association of the platelet membrane glycoprotein I a C807T gene polymorphism with aspirin resistance
Su Guanhua et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2007)
Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
M. K. Pasanen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Cytochrome P4502C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients
Betti Giusti et al.
PHARMACOGENETICS AND GENOMICS (2007)
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
J. T. Brandt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Arg389Gly-β1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol
Lu Chen et al.
PHARMACOGENETICS AND GENOMICS (2007)
Clopidogrel non responsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis
Jaapjan D. Snoep et al.
AMERICAN HEART JOURNAL (2007)
Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis
H. Schelleman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
Marie Lordkipanidze et al.
EUROPEAN HEART JOURNAL (2007)
Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin
Qing Li et al.
PHARMACOGENOMICS (2007)
The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension
Jean Lefebvre et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or β-blockers
Hedi Schelleman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Synergistic polymorphisms of β1 and α2c-adrenergic receptors and the influence on left ventricular ejection fraction response to β-blocker therapy in heart failure
Maximilian T. Lobmeyer et al.
PHARMACOGENETICS AND GENOMICS (2007)
Evaluation of Genetic Factors for Warfarin Dose Prediction
Michael D. Caldwell et al.
CLINICAL MEDICINE & RESEARCH (2007)
Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor
Xiaowen Su et al.
CIRCULATION (2007)
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Marcel M. C. Hovens et al.
AMERICAN HEART JOURNAL (2007)
Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome
Thomas Cuisset et al.
THROMBOSIS RESEARCH (2007)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Impact of P-glycoprotein on clopidogrel absorption
Dirk Taubert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Clinical implications of pharmacogenomics of statin treatment
L. M. Mangravite et al.
PHARMACOGENOMICS JOURNAL (2006)
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P4502C9
Lai-San Tham et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin
Mikko Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
Jean-Sebastien Hulot et al.
BLOOD (2006)
A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
Stephen B. Liggett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
β1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension
Jie Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Statin safety: A systematic review
M Law et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450
JLF Rehmel et al.
DRUG METABOLISM AND DISPOSITION (2006)
Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers
P Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients
R Ismail et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene
DJ Angiolillo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
AO Maree et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol:: A prospective clinical study
R Fux et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Ser49Gly of β1-adrenergic receptor is associated with effective β-blocker dose in dilated cardiomyopathy
Y Magnusson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Aspirin resistance
A Szczeklik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
The effect of glycoprotein IIIa PIA1/A2 polymorphism on the PFA-100 response to GP IIbIIIa receptor inhibitors -: The importance of anticoagulants used
K Aalto-Setälä et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2005)
Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease
S Ziegler et al.
STROKE (2005)
Aspirin resistance and a single gene
BK Jefferson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
β-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure
SG Terra et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure
P de Groote et al.
PHARMACOGENETICS AND GENOMICS (2005)
Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism
GS Bleumink et al.
PHARMACOGENETICS AND GENOMICS (2005)
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
M Wadelius et al.
PHARMACOGENOMICS JOURNAL (2005)
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects
SM Boekholdt et al.
CIRCULATION (2005)
Genetic polymorphisms of cytochrome P4502C9 causing reduced phenprocoumon (S)-7-hydroxylation in vitro and in vivo
M Ufer et al.
XENOBIOTICA (2004)
Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype
MA Hillman et al.
PHARMACOGENETICS (2004)
Cardiovascular drug class specificity:: β-blockers
MJ Reiter
PROGRESS IN CARDIOVASCULAR DISEASES (2004)
807 C/T polymorphism of the glycoprotein la gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment
DJ Angiolillo et al.
BLOOD COAGULATION & FIBRINOLYSIS (2004)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
UM Zanger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Beta1-adrenergic receptor gene polymorphisms and response to betal1-adrenergic receptor blockade in patients with essential hypertension
J Karlsson et al.
CLINICAL CARDIOLOGY (2004)
PIA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation
DJ Angiolillo et al.
BLOOD COAGULATION & FIBRINOLYSIS (2004)
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease
JF Carlquist et al.
AMERICAN HEART JOURNAL (2003)
A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study
DJ Freeman et al.
EUROPEAN HEART JOURNAL (2003)
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
SB Harrap et al.
HYPERTENSION (2003)
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study
HL White et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure
DM Kaye et al.
PHARMACOGENETICS (2003)
β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
JA Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
A common β1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade
GG Sofowora et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Comparative pharmacology of GP IIb/IIIa antagonists
K Schrör et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2003)
Genetic variation in cyclooxygenase 1: Effects on response to aspirin
MK Halushka et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: Evidence for publication bias
WRP Agema et al.
AMERICAN HEART JOURNAL (2002)
No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors
AA Weber et al.
PHARMACOGENETICS (2002)
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment
T Rau et al.
PHARMACOGENETICS (2002)
Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors
AA Weber et al.
THROMBOSIS RESEARCH (2002)
A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men
S Liu et al.
ATHEROSCLEROSIS (2002)
Reduced inhibition by abciximab in platelets with the PIA2 polymorphism
GL Wheeler et al.
AMERICAN HEART JOURNAL (2002)
Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes
FF O'Connor et al.
BLOOD (2001)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
All kinesin superfamily protein, KIF, genes in mouse and human
H Miki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Calmin, a protein with calponin homology and transmembrane domains expressed in maturing spermatogenic cells
Z Ishisaki et al.
GENOMICS (2001)
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk -: The Framingham study
JM Ordovas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
Å Hjalmarson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Platelet GP IIIa PlA polymorphisms display different sensitivities to agonists
AD Michelson et al.
CIRCULATION (2000)
Share Paper
